セルライト治療の世界市場：2022年～2029年

当レポートでは、世界のセルライト治療の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、アンメットニーズ、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 セルライト治療市場：調査手法・調査範囲

第2章 セルライト治療市場：市場の定義と概要

第3章 セルライト治療市場：エグゼクティブサマリー

第4章 セルライト治療市場：市場力学

• 市場に影響を与える要因
  • 促進要因
  • 抑制要因
  • 市場機会
  • 影響分析

第5章 セルライト治療市場：産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• アンメットニーズ

第6章 セルライト治療市場：COVID-19の分析

• COVID-19：市場への影響分析
• COVID-19渦中の価格ダイナミクス
• 需給スペクトル
• パンデミック時の政府の市場関連イニシアチブ
• 製造業者の戦略的イニシアチブ
• 総論

第7章 セルライト治療市場：処置別

• 最小侵襲
• 非侵襲
• 局所

第8章 セルライト治療市場：セルライトタイプ別

• ソフトセルライト
• ハードセルライト
• 浮腫性セルライト

第9章 セルライト治療市場：エンドユーザー別

• 病院
• 美容外科センター
• 専門皮膚科クリニック
• その他

第10章 セルライト治療市場：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第11章 セルライト治療市場：競合情勢

• 主な展開・戦略
• 企業シェア分析
• 製品ベンチマーキング

第12章 セルライト治療市場：企業プロファイル

• Endo Aesthetics LLC
• Merz Pharma GmbH & Co KgaA
• Inceler Medikal Co Ltd
• Candela Corporation
• Cynosure
• Cutera Inc
• Zimmer Aesthetics
• Cymedics GmbH & Co KG
• Beijing Nubway S&T Co Ltd

第13章 セルライト治療市場：DataM

Market Overview

The global cellulite treatment market is estimated to reach a CAGR of 9.2 % during the forecast period (2022-2029).

Cellulite is a benign skin condition that causes lumpy, dimpled skin on the thighs, hips, buttocks, and abdomen. Women are the ones who are most affected.

Market Dynamics

The factors influencing the global cellulite treatment market are the increasing demand for cellulite treatment and the growing prevalence of cellulite.

The increasing demand for the treatment of cellulite is expected to drive the market growth

Connective tissue bands pull the skin overlying certain areas of fat downward to the deeper tissues, causing cellulite. As a result, the surface becomes uneven. Due to differences in fat, muscle, and connective tissue distribution, cellulite affects women more than men. It is estimated that 80 to 90 percent of women are affected somehow. Cellulite isn't dangerous.

Topical treatments may help reduce the appearance of cellulite, but the results may not last. Creams are supposed to tighten the skin, making it look smoother and firmer. They also add moisture, which can help with cellulite appearance. Creams, on the other hand, do not remove cellulite. Instead, they make it appear less prominently. Fat cells can still be found beneath the skin. Caffeine is a common ingredient in cellulite creams. Caffeine acts as a diuretic and increases blood flow to the area. This can alter the fat's water content, potentially reducing the appearance of cellulite. By thickening the outer layer of skin, products containing 0.3 percent retinol may help reduce cellulite's appearance. Hence, with increasing demand, various treatment options are being introduced and expected to drive market growth.

Limitations associated with the treatment of cellulite are expected to hamper the market growth

CoolSculpting is a non-invasive procedure that does not require any cuts, anesthesia, or the insertion of any instruments into the body. In 2018, it was the most popular body sculpting procedure in the US. CoolScuplting is a fat-loss technique that targets fat in areas of the body that are more difficult to lose through diet and exercise. It has fewer side effects than traditional fat-reduction procedures like liposuction. However, while it is generally safe, it has some potential side effects. Some people experience soreness at the CoolSculpting treatment site, similar to what they might experience after a strenuous workout or a minor muscle injury. Others have complained of stinging, firmness, mild discoloration, swelling, and itching. The cost of the procedure is also too high. For instance, the average cost of CoolSculpting treatment is $2,000-4,000. However, areas requiring small applicators, such as the chin and jaw, can cost anywhere from $700 to 900 dollars.

COVID-19 Impact Analysis

The pandemic caused major disruptions in the cellulite treatment market. Lockdown restrictions in several economies around the world caused a halt to non-essential therapies and procedures and a significant drop in hospital and clinic visits. Furthermore, people's declining socioeconomic status significantly reduced their expenditures on beauty and aesthetics. However, with the lockdown restrictions nearly lifted and increased vaccination campaigns on the rise, cellulite treatment is expected to become more popular in the coming years.

Segment Analysis

Minimally Invasive procedure segment is expected to dominate the market growth

Cellfina is the most effective treatment for cellulite reduction and the appearance of smoother, more attractive skin. The FDA has approved this minimally invasive, effective technique for treating this skin condition. Furthermore, research has shown that this treatment can improve skin for three years. When fibrous bands put too much pressure on the skin, cellulite develops. Dimples and puckering are the results of this pressure. The cellulite reduction treatment improves appearance by breaking up the fibrous bands that cause the skin to look dimpled and uneven with a special device. Subcision is a technique that has been used to improve the appearance of scars and wrinkles.

The Cellfina is a highly precise instrument that gently releases the fibrous connective bands that pull the skin down and cause the visible dimpling. Cellfina targets cellulite and has been shown to smooth the skin in the treated area. The fibrous connective bands woven through the connective tissues of the upper legs and buttocks cause cellulite. There have been cellulite-fixing solutions for years, but they never address the root cause of cellulite.

Geographical Analysis

North America region is expected to hold the largest market share in the global cellulite treatment market

An increase in the adoption of advanced technologies in the region and an increase in the number of obesity cases due to a sedentary lifestyle is expected to drive the market growth.

There has been a shift away from surgical procedures and toward non-invasive treatments in recent years. According to the 2018 Plastic Surgery Statistics, 5.8 million reconstructive procedures were performed globally in 2018, down from the previous two years, indicating that non-invasive treatments are driving the market in the region. Moreover, on 9th July 2020, Collagenase clostridium histolyticum-aaes (Qwo, Endo International) was approved by the US Food and Drug Administration (FDA) to treat moderate-to-severe cellulite in the buttocks in adults women, making it the first FDA-approved injectable cellulite treatment.

Competitive Landscape

The global cellulite treatment market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Merz Pharma GmbH & Co KgaA, Inceler Medikal Co Ltd, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics, Cymedics GmbH & Co KG, Beijing Nubway S&T Co Ltd, Endo Aesthetics LLC

Endo Aesthetics LLC

Overview: Endo Aesthetics is a research and development-driven company. Endo Aesthetics is advancing solutions to address unmet needs, starting with the first FDA-approved injectable treatment for buttock cellulite.

Product Portfolio: QWO is a prescription drug used to treat moderate to severe cellulite in adult women's buttocks.

Why Purchase the Report?

• Visualize the composition of the global cellulite treatment market segmentation By procedure, cellulite type, and end-user highlighting the key commercial assets and players.
• Identify commercial opportunities in global cellulite treatment market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of global cellulite treatment market- level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global cellulite treatment market report would provide an access to an approx. 45+market data table, 40+figures and 185 pages.

Target Audience

• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Key Development: On July 6, 2020, Endo International plc's Qwo (collagenase clostridium histolyticum-aaes) was approved by the US Food and Drug Administration (FDA) to treat moderate to severe cellulite in adult women's buttocks.

Table of Contents

1. Cellulite Treatment MarketMethodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Cellulite Treatment Market- Market Definition and Overview

3. Cellulite Treatment Market- Executive Summary

• 3.1. Market Snippet By Procedure
• 3.2. Market Snippet By Cellulite Type
• 3.3. Market Snippet By End-User
• 3.4. Market Snippet By Region

4. Cellulite Treatment Market-Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers:
    • 4.1.1.1. The increasing demand for the treatmement of cellulite
  • 4.1.2. Restraints:
    • 4.1.2.1. Limitations associated with the treatment of cellulite
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Cellulite Treatment Market- Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs

6. Cellulite Treatment Market- COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Cellulite Treatment Market- By Procedure

• 7.1. Introduction
• 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
• 7.3. Market Attractiveness Index, By Procedure
  • 7.3.1. Minimally Invasive
    • 7.3.1.1.1. Introduction
    • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3.2. Non-Invasive
  • 7.3.3. Topical

8. Cellulite Treatment Market-By Cellulite Type

• 8.1. Introduction
• 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
• 8.3. Market Attractiveness Index, By Cellulite Type
  • 8.3.1. Soft Cellulite
    • 8.3.1.1.1. Introduction
    • 8.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3.2. Hard Cellulite
  • 8.3.3. Edematous Cellulite

9. Cellulite Treatment Market- By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Cosmetic Surgery Centers
• 9.4. Specialized Dermatology Clinics
• 9.5. Other

10. Cellulite Treatment Market- By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Cellulite Type
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Cellulite Treatment Market- Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Product Benchmarking

12. Cellulite Treatment Market- Company Profiles

• 12.1. Endo Aesthetics LLC*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Merz Pharma GmbH & Co KgaA
• 12.3. Inceler Medikal Co Ltd
• 12.4. Candela Corporation
• 12.5. Cynosure
• 12.6. Cutera Inc
• 12.7. Zimmer Aesthetics
• 12.8. Cymedics GmbH & Co KG
• 12.9. Beijing Nubway S&T Co Ltd

LIST NOT EXHAUSTIVE

13. Cellulite Treatment Market- DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us